The present disclosure relates generally to the field of medical devices. More particularly, some embodiments relate to methods of accessing the carotid artery via the jugular vein to perform treatments on a medical condition.
The written disclosure herein describes illustrative embodiments that are non-limiting and non-exhaustive. Reference is made to certain of such illustrative embodiments that are depicted in the figures, in which:
Certain medical procedures require access to the carotid artery in order to treat a patient for certain medical conditions. In some procedures the carotid artery is accessed through open surgical procedure. An exemplary procedure that includes open surgery is carotid endarterectomy in which the carotid artery is clamped and cut open and then scraped to remove fatty plaque to treat a blockage in the carotid artery. Very ill and/or elderly patients may have a difficult time tolerating an open surgical procedure under general anesthesia.
Another method of accessing the carotid artery is to access the carotid artery percutaneously via the femoral artery and advancing treatment devices such as catheters through the aortic arch to the carotid artery. One such exemplary procedure is carotid artery invention by advancing a filter and an angioplasty balloon catheter percutaneously (via a sheath) form the femoral artery into the aortic arch and then into the blocked carotid artery under local anesthesia. However, in some patients, the aortic arch may be difficult to navigate due to age-related calcification and/or tortuosity.
The present disclosure includes methods and devices for accessing a patient's carotid artery via the patient's jugular vein, without open surgery or having to pass a treatment device through the patient's aortic arch. It is within the scope of this disclosure to access the carotid artery at a remote access point, e.g., femoral vein, brachial vein, basilic vein, cephalic vein, median antecubital, median antebrachial, etc., or directly though the patient's neck.
The components of the embodiments as generally described and illustrated in the figures herein can be arranged and designed in a wide variety of different configurations. Thus, the following more detailed description of various embodiments, as represented in the figures, is not intended to limit the scope of the present disclosure, but is merely representative of various embodiments. While various aspects of the embodiments are presented in drawings, the drawings are not necessarily drawn to scale unless specifically indicated.
The phrase “coupled to” is broad enough to refer to any suitable coupling or other form of interaction between two or more entities. Two components may be coupled to each other even though they are not in direct contact with each other. For example, two components may be coupled to each other through an intermediate component. The phrase “fluid communication” is used in its ordinary sense, and is broad enough to refer to arrangements in which a fluid (e.g., a gas or a liquid) can flow from one element to another element when the elements are in fluid communication with each other.
The terms “proximal” and “distal” are opposite directional terms. For example, the distal end of a device or component is the end of the component that is furthest from the practitioner during ordinary use. The proximal end refers to the opposite end or the end nearest the practitioner during ordinary use.
The vascular catheter 42 may comprise a catheter tip 47 at the distal end of the vascular catheter 42. The catheter tip 47 may be tapered, beveled, conical or comprise other shapes or structures. The catheter tip 47 in
The handle 44 may include a top portion 45A and a bottom portion 45B.
Referring to
In addition to the guidewire lumen 46, the device 40 may have a stylet lumen 50 extending from the handle 44 to an opening toward the distal end of the vascular catheter 42. In some embodiments, the stylet lumen 50 curves at its distal end to form a camming surface 56, as illustrated in
In some embodiments the stylet lumen 50 does not have a curved camming surface 56. For example, the stylet lumen 50 may be substantially cylindrical as illustrated in
The stylet 58 (formed, e.g., from Nitinol with a diameter of 0.014 inches) enclosed by the cover tube 60 (such as a 0.025 inch diameter Nitinol hypotube) extends from an actuator (e.g., slide button 51, spring load mechanism 52, and/or stylet release button 53), in the handle 44 toward the distal end of the device 40. In some embodiments the cover tube 60 has a preformed curved or deflected tip at its distal end. For example, the performed curve may be between 30° and 60° of the longitudinal axis of vascular catheter 42. The optional camming surface 56 may promote the curvature of the cover tube 60.
Stylet 58 may have a sharp distal point 62 adapted to penetrate tissue, such as blood vessels, muscle, and skin. The sharp distal point 62 may be part of a tip designed to have various dimensions and shapes. In some embodiments, the tip 62 may be faceted. For example, the tip 62 may include three flat surfaces that intersect to form a sharp distal point. In some embodiments, tip 62 may be a conical tip. The conical tip may form an angle of about 10° with the shaft of the stylet 58.
To gain access of the carotid artery 18, vascular catheter 40 may be inserted into the femoral vein 12 over the guidewire 30 (with the guidewire disposed as shown in
The arrows (F1 and F2) in
The cover tube 60 may be advanced out of opening into an primed configuration by moving a slide button 51 proximally in handle 44, at which point the cover tube 60 assumes its curved shape, as shown in
The orientation of the extended cover tube 60 may be determined based on the orientation of the handle 44. The slide button 51 engages with the top portion 45A of the handle 44. In the illustrated embodiment, the slide button 51, is disposed substantially perpendicular to a plane defined by the opposing wings 48 that extends along a length of the handle 44 e.g., the plane defined by the curve where the top portion 45A of the handle 44 contacts the bottom portion 45B of the handle 44. The cover tube 60 extends upwards from the stylet lumen 50 and is also substantially perpendicular to the plane defined by the opposing wings 48 extending along a length of the handle 44. The positioning and orientation of the cover tube 60 after it has been advanced may also be visually verified, for example using fluoroscopy prior to deploying the stylet 58. The stylet actuator is loaded by pulling proximally on a spring load mechanism 52 in the handle 44, as illustrated in
Various sizes may be used for the cover tube 60. The configuration of the pre-formed cover tube 60 may be varied to use different shapes. The length and pre-formed configuration of the cover tube 60 may be selected based on the size of the vessel to be accessed.
In some embodiments, the cover tube 60 is not fully extended from the vascular catheter 42. For example, the cover tube 60 may not be fully extended to accommodate the specific geometry and size of the vessel. In smaller diameter blood vessels there may not be enough space to fully extend the cover tube; however, the cover tube 60 and stylet 58 may properly function partially extended from the vascular catheter 42.
After the stylet 58 has puncture the carotid artery 18, the guidewire 30, vascular catheter 42, and cover tube 60 may be withdrawn from the jugular vein 14. An access catheter 70 may be introduced and advanced along stylet 58 through the femoral vein 12 to the jugular vein 14 and into the carotid artery 18. Once the access catheter 70 has been introduced into the carotid artery 18, it may be used to perform a number of different medical procedures via the carotid artery 18. Access catheter 70 may advance a particular treatment device or tool 72, for treating the patient. Exemplary treatment devices 72 may include angioplasty balloons, stents, filters, aneurysm stents, etc. These devices 72 may be used to treat a blockage in the carotid artery, treat an embolism in the brain (stroke), treat an aneurysm, place a filter, remove fatty plaque, etc.
After the procedure is concluded, the stylet 58, access catheter 70, and any treatment devices 72 may be withdrawn from the carotid artery 18 and the jugular vein 14. In addition, a closure device 80 may be introduced into the jugular vein 14 adjacent to the opening to close the opening between the jugular vein 14 and the carotid artery 18, as illustrated in
The puncture needle 10 may be inserted at a number of different orientations, for example, at an upward angle, a downward angel, etc.
After the distal tip 21 of the puncture needle 10 is in the carotid artery 18, a guidewire 30 may be advanced through the puncture needle 10 into the carotid artery 18, as illustrated in
After the completion of the carotid artery procedure, a closure device 80 may be introduced into the jugular vein 14 adjacent to the opening to close the opening between the jugular vein 14 and the carotid artery 18, as illustrated in
The closure device 80 may be inserted via the interventional sheath 26 (after it has been withdrawn from the carotid artery 18, but before withdrawing it from the internal jugular vein 14). Alternatively, the closure device 80 may be implanted using a separate catheter (not shown) that has been advanced from a remote entry point in the femoral vein 12 into the jugular vein 14.
In step 1704, the practitioner may access the carotid artery 18 via the jugular vein 14. For example, as previously discussed, the practitioner may access the carotid artery 18 by piercing the carotid artery 18 after piercing the jugular vein 14 with the puncture needle 10. Alternatively, the practitioner may advance a guidewire 30 and a vascular catheter 42 to the jugular vein 14 and pierce the carotid artery 18 with the stylet 58.
In step 1706, once the practitioner has gained access to the carotid artery 18, the practitioner may introduce or advance a treatment device for treating a medical condition via the carotid artery 18.
In step 1708, after the medical condition has been treated, the treatment device 72 may be removed and the practitioner may introduce a closure device 80 for closing the opening between the jugular vein 14 and the carotid artery 18.
Any methods disclosed herein include one or more steps or actions for performing the described method. The method steps and/or actions may be interchanged with one another. In other words, unless a specific order of steps or actions is required for proper operation of the embodiment, the order and/or use of specific steps and/or actions may be modified. Moreover, sub-routines or only a portion of a method described herein may be a separate method within the scope of this disclosure. Stated otherwise, some methods may include only a portion of the steps described in a more detailed method.
Reference throughout this specification to “an embodiment” or “the embodiment” means that a particular feature, structure, or characteristic described in connection with that embodiment is included in at least one embodiment. Thus, the quoted phrases, or variations thereof, as recited throughout this specification are not necessarily all referring to the same embodiment.
Similarly, it should be appreciated by one of skill in the art with the benefit of this disclosure that in the above description of embodiments, various features are sometimes grouped together in a single embodiment, figure, or description thereof for the purpose of streamlining the disclosure. This method of disclosure, however, is not to be interpreted as reflecting an intention that any claim requires more features than those expressly recited in that claim. Rather, as the following claims reflect, inventive aspects lie in a combination of fewer than all features of any single foregoing disclosed embodiment. Thus, the claims following this Detailed Description are hereby expressly incorporated into this Detailed Description, with each claim standing on its own as a separate embodiment. This disclosure includes all permutations of the independent claims with their dependent claims.
Recitation in the claims of the term “first” with respect to a feature or element does not necessarily imply the existence of a second or additional such feature or element. It will be apparent to those having skill in the art that changes may be made to the details of the above-described embodiments without departing from the underlying principles of the present disclosure.
This application is a divisional application of U.S. patent application Ser. No. 15/835,114, filed on Dec. 7, 2017 and titled “Trans-Jugular Carotid Artery Access Methods,” which claims priority to U.S. Provisional Application No. 62/432,369 filed Dec. 9, 2016, and titled “Trans-Jugular Carotid Artery Access Method,” U.S. Provisional Application No. 62/433,634 filed Dec. 13, 2016, and titled “Trans-Jugular Carotid Artery Access Method,” and U.S. Provisional Application No. 62/440,735 filed Dec. 30, 2016, and titled “Trans-Jugular Carotid Artery Access Method,” all of which are hereby incorporated by reference in their entireties.
Number | Name | Date | Kind |
---|---|---|---|
4559039 | Ash et al. | Dec 1985 | A |
4790825 | Bernstein et al. | Dec 1988 | A |
4966163 | Kraus et al. | Oct 1990 | A |
5421348 | Larnard | Jun 1995 | A |
5492530 | Fischell et al. | Feb 1996 | A |
5685820 | Riek et al. | Nov 1997 | A |
5733248 | Adams et al. | Mar 1998 | A |
6047700 | Eggers et al. | Apr 2000 | A |
6102926 | Tartaglia et al. | Aug 2000 | A |
6190353 | Makower et al. | Feb 2001 | B1 |
6217527 | Selmon et al. | Apr 2001 | B1 |
6475226 | Belef et al. | Nov 2002 | B1 |
6485513 | Fan | Nov 2002 | B1 |
6508777 | MacOviak et al. | Jan 2003 | B1 |
6554794 | Mueller et al. | Apr 2003 | B1 |
6623480 | Kuo et al. | Sep 2003 | B1 |
6709444 | Makower | Mar 2004 | B1 |
6726677 | Flaherty et al. | Apr 2004 | B1 |
6955657 | Webler | Oct 2005 | B1 |
7008979 | Schottman et al. | Mar 2006 | B2 |
7374567 | Heuser | May 2008 | B2 |
7648517 | Makower et al. | Jan 2010 | B2 |
8019420 | Hine et al. | Sep 2011 | B2 |
8241311 | Ward et al. | Aug 2012 | B2 |
8374680 | Thompson | Feb 2013 | B2 |
8409236 | Pillai | Apr 2013 | B2 |
8568435 | Pillai et al. | Oct 2013 | B2 |
9220874 | Pillai et al. | Dec 2015 | B2 |
20010012924 | Milo et al. | Aug 2001 | A1 |
20010023346 | Loeb | Sep 2001 | A1 |
20020004666 | Schwager et al. | Jan 2002 | A1 |
20020029060 | Hogendijk et al. | Mar 2002 | A1 |
20020120250 | Altman | Aug 2002 | A1 |
20020122877 | Harish et al. | Sep 2002 | A1 |
20020133168 | Smedley et al. | Sep 2002 | A1 |
20020169377 | Khairkhahan et al. | Nov 2002 | A1 |
20030040771 | Hyodoh | Feb 2003 | A1 |
20040039371 | Tockman et al. | Feb 2004 | A1 |
20040059280 | Makower et al. | Mar 2004 | A1 |
20040082850 | Bonner et al. | Apr 2004 | A1 |
20040133168 | Salcudean et al. | Jul 2004 | A1 |
20040181150 | Evans et al. | Sep 2004 | A1 |
20040181238 | Zarbatany et al. | Sep 2004 | A1 |
20050101984 | Chanduszko et al. | May 2005 | A1 |
20050149097 | Regnell et al. | Jul 2005 | A1 |
20050209579 | Yacoubian et al. | Sep 2005 | A1 |
20050279370 | Aboul-Hosn | Dec 2005 | A1 |
20060009737 | Whiting et al. | Jan 2006 | A1 |
20060135962 | Kick et al. | Jun 2006 | A1 |
20060173440 | Lamson | Aug 2006 | A1 |
20060247750 | Seifert et al. | Nov 2006 | A1 |
20070021767 | Breznock | Jan 2007 | A1 |
20070203515 | Heuser | Aug 2007 | A1 |
20080082136 | Gaudini | Apr 2008 | A1 |
20080125748 | Patel | May 2008 | A1 |
20080154172 | Mauch | Jun 2008 | A1 |
20080171944 | Brenneman et al. | Jul 2008 | A1 |
20080215008 | Nance et al. | Sep 2008 | A1 |
20080249565 | Michler et al. | Oct 2008 | A1 |
20090024072 | Chado | Jan 2009 | A1 |
20090112050 | Farnan et al. | Apr 2009 | A1 |
20090240122 | Avitsian | Sep 2009 | A1 |
20100185216 | Garrison | Jul 2010 | A1 |
20100249491 | Farnan et al. | Sep 2010 | A1 |
20110178530 | Bly | Jul 2011 | A1 |
20110190871 | Trollsas | Aug 2011 | A1 |
20110295206 | Gurley | Dec 2011 | A1 |
20120130468 | Khosravi | May 2012 | A1 |
20120136247 | Pillai | May 2012 | A1 |
20120136366 | Pillai | May 2012 | A1 |
20120290075 | Mortisen | Nov 2012 | A1 |
20130006282 | Wilkinson | Jan 2013 | A1 |
20130072957 | Anderson | Mar 2013 | A1 |
20130324901 | Pillai | Dec 2013 | A1 |
20130324967 | Pillai | Dec 2013 | A1 |
20140018837 | Zhou et al. | Jan 2014 | A1 |
20140046346 | Hentges | Feb 2014 | A1 |
20140142418 | Gurley et al. | May 2014 | A1 |
20140142677 | Heuser et al. | May 2014 | A1 |
20150320357 | Kauaguntla et al. | Nov 2015 | A1 |
20170035591 | De Pablo et al. | Feb 2017 | A1 |
20170056625 | Pillai | Mar 2017 | A1 |
20170296798 | Kume | Oct 2017 | A1 |
20180161551 | Pillai | Jun 2018 | A1 |
20190321600 | Pillai | Oct 2019 | A1 |
20200069919 | Pillai | Mar 2020 | A1 |
Number | Date | Country |
---|---|---|
2004018029 | Mar 2004 | WO |
2005053547 | Jun 2005 | WO |
2011068540 | Jun 2011 | WO |
2013119547 | Aug 2013 | WO |
Entry |
---|
Office Action dated Sep. 24, 2020 for U.S. Appl. No. 15/834,998. |
Office Action dated Feb. 2, 2021 for U.S. Appl. No. 15/855,672. |
Office Action dated Feb. 3, 2021 for U.S. Appl. No. 15/834,998. |
Notice of Allowance dated Jan. 28, 2019 for U.S. Appl. No. 14/949,243. |
Notice of Allowance dated Feb. 5, 2020 for U.S. Appl. No. 15/835,114. |
Notice of Allowance dated Mar. 19, 2019 for U.S. Appl. No. 15/464,055. |
Notice of Allowance dated May 1, 2019 for U.S. Appl. No. 15/347,478. |
Office Action dated Jan. 30, 2018 for U.S. Appl. No. 14/949,243. |
Office Action dated Apr. 13, 2020 for U.S. Appl. No. 15/834,998. |
Office Action dated May 30, 2017 for U.S. Appl. No. 14/949,243. |
Office Action dated Jun. 14, 2018 for U.S. Appl. No. 14/949,243. |
Office Action dated Aug. 29, 2019 for U.S. Appl. No. 15/835,114. |
Office Action dated Sep. 7, 2018 for U.S. Appl. No. 15/347,478. |
Office Action dated Sep. 27, 2018 for U.S. Appl. No. 15/464,055. |
Office Action dated Oct. 2, 2018 for U.S. Appl. No. 14/949,243. |
Office Action dated Oct. 23, 2019 for U.S. Appl. No. 15/834,998. |
Faul, et al., Vascular Disease Management, vol. 5 No. 5 ,Sep./Oct. 2008 ,128-133. |
Huang, et al., Evaluation of the Needle Technique for Producing an Arteriovenous Fistula, Journal of Applied Physiology, vol. 77(6) ,Dec. 1994 ,2907-2911. |
Khanna, et al., sharpening of Hollow Silicon Microneedles to Reduce Skin Penetration Force, ,Mar. 15, 2010, 045011. |
Lumend Inc., et al., Outback LTD Re-Entry Catheter; Product Resources (http://www.lumend.com/Images/Technology/Products/brochure.pdf), ,Jul. 19, 2006. |
Mewissen, et al., Revascularization of Long FP Arterial Occlusions, Endovascular Today ,Mar. 2004 ,2-4. |
O'Callaghan, et al., Dynamics of Stab Wounds: Force Required for Penetration of Various Cadaveric Himan Tissues, Forensic Sci. Int'l., vol. 104 ,Oct. 11, 1999 ,173-178. |
Office Action dated May 25, 2021 for U.S. Appl. No. 15/834,998. |
Office Action dated Jun. 22, 2021 for U.S. Appl. No. 15/855,672. |
Number | Date | Country | |
---|---|---|---|
20200338320 A1 | Oct 2020 | US |
Number | Date | Country | |
---|---|---|---|
62440735 | Dec 2016 | US | |
62433634 | Dec 2016 | US | |
62432369 | Dec 2016 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15835114 | Dec 2017 | US |
Child | 16847281 | US |